Treatment of daytime urinary incontinence in children: a systematic review of randomized controlled trials

Related Experiment Videos

Premala Sureshkumar1, Wendy Bower, Jonathan C Craig

  • 1Centre for Kidney Research, Children's Hospital at Westmead, University of Sydney, Westmead, NSW 2145, Australia.

Insights

This study found no proven benefits for interventions treating childhood daytime urinary incontinence. Current treatments like oxybutynin and biofeedback showed no significant improvement over placebo in trials.

Area of Science:

  • Pediatric Urology
  • Clinical Trials
  • Evidence-Based Medicine

Background:

  • Daytime urinary incontinence is a common condition in children.
  • Various interventions exist, but their efficacy requires rigorous evaluation.

Purpose of the Study:

  • To systematically review the benefits and harms of interventions for children with primary daytime urinary incontinence.
  • To assess the effectiveness of treatments for urge syndrome and dysfunctional voiding.

Main Methods:

  • Comprehensive literature search of multiple databases (Cochrane, MEDLINE, EMBASE) and other sources.
  • Quality assessment of identified randomized trials and data extraction by two independent reviewers.
  • Meta-analysis using random effects models to derive summary estimates of treatment effects.

Main Results:

  • Reviewed randomized trials included terodiline, daytime alarms, imipramine, and biofeedback/oxybutynin, involving 383 children.
  • No intervention demonstrated statistically significant effectiveness in treating daytime urinary incontinence.
  • A trial comparing oxybutynin and biofeedback to placebo showed no difference in treatment outcomes after nine months.

Conclusions:

  • Current evidence does not support the effectiveness of any intervention for childhood daytime urinary incontinence.
  • Further high-quality research is needed to identify beneficial treatments for this condition.
Abstract